CD274 and neoplasm: In the renewed model tumor, an uptake at the periphery of PD-L1-positive tumors (approx. 1.6 %IA/g for C3) and a lower uptake for PD-L1-negative tumors (approx. 1.1 %IA/g for C3) were observed.